Navigation Links
Cholesterol Drug Zetia Doesn't Cut Heart Attack Risk: Study
Date:1/14/2008

Results might also pertain to Vytorin, which contains Zetia, experts say

MONDAY, Jan. 14 (HealthDay News)-- The long-awaited results of a trial of Zetia, a cholesterol-lowering drug prescribed to about a million Americans, shows the drug confers no medical benefit to users.

In fact, the pace at which artery-clogging plaques formed within vessels almost doubled in patients taking Zetia (ezetimibe) along with another cholesterol-lowering drug, Zocor (simvastatin), compared to those taking Zocor alone, the study found.

The two medications -- ezetimibe plus simvastatin -- are also marketed in one prescription pill, called Vytorin. About 60 percent of U.S. patients who are taking Zetia now receive the drug as part of Vytorin.

But the new two-year trial of 720 patients sheds doubt on whether it makes any sense for people battling cholesterol to take Vytorin versus Zocor alone, experts said. The study was funded by the two companies that make Zetia, Merck and Schering-Plough.

"This wraps it up," said Dr. Steven E. Nissen, chairman of cardiology at the Cleveland Clinic. "That's all there is. There just isn't any evidence that adding ezetimibe to simvastatin produces any advantage."

No one is disputing that Zetia can lower levels of LDL "bad" cholesterol by 15 percent to 20 percent -- that had been shown in previous trials. However, whether that reduction led to any greater lowering of heart attack or stroke risk had remained unclear.

The new ENHANCE trial -- which involved patients with a genetic condition that causes abnormally high levels of blood cholesterol -- found no such added benefit. According to a statement released by the two drug companies Monday, researchers found no statistically significant difference in heart attacks or stroke among trial participants who took Zetia plus Zocor, a widely used cholesterol-lower drug, versus those who got Zocor alone.

The study also n
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

4

GOOD

Page: 1 2 3

Related medicine news :

1. Seven New Cholesterol Genes Discovered
2. Corazonas Launches First and Only Cholesterol-Reducing Potato Chips
3. High triglycerides, other cholesterol raise risk of stroke
4. New Type of Cholesterol-Lowering Drug Shows Promise
5. Study Finds Cholesterol Fine-Tunes Hearing
6. Consumers Union Opposes Over-the-Counter Cholesterol Drug
7. Cholesterol-Stroke Relationship Puzzles Researchers
8. Knowing Heart Risk Keeps Patients on Cholesterol Drugs
9. Low Levels of Good Cholesterol May Slow Stroke Recovery
10. CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
11. Many Patients Stop Taking Cholesterol-Lowering Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol Drug Zetia Doesn't Cut Heart Attack Risk: Study
Cholesterol Drug Zetia Doesn't Cut Heart Attack Risk: Study
(Date:5/22/2012)... , , TUESDAY, May 22 (HealthDay News) -- Two preliminary ... both the detection and treatment of pancreatic cancer. ... said they have fashioned a vaccine that, in early ... attacking cancer cells. The team -- from Case ... Cancer Center at University Hospitals Case Medical Center in ...
(Date:5/22/2012)... Two popular MTV programs about teenage pregnancy -- "16 ... national debate. Critics said the shows glamorized teenage pregnancy, ... study by an Indiana University professor suggests they,re both ... journal Sexuality & Culture, focused on female ... pregnancy among this demographic. , When the programs were ...
(Date:5/22/2012)... a microfluidic chip to test for latent tuberculosis. They ... reliable than current testing for the disease. , "Our ... time," said Ying Liu, a research specialist working with ... Biomedical Engineering. , The team has already conducted testing ... United States. , About one-third of the world,s population ...
(Date:5/22/2012)... , , MONDAY, May 21 (HealthDay News) -- In ... debate, a prominent U.S. government advisory panel is ... be screened for prostate cancer by undergoing the ... Preventive Services Task Force, an independent group of ... PSA screening results in overdiagnosis of prostate cancer ...
(Date:5/22/2012)... May 22 (HealthDay News) -- New Mexico has the ... while New Jersey has the lowest rate, according to ... 98 per 100,000 people, while New Jersey,s is about ... deaths is about 58 per 100,000, according to the ... the Robert Wood Johnson Foundation. Injuries that result ...
Breaking Medicine News(10 mins):Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 2Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 3Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 4Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 2Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 3Health News:New TB test promises to be cheap and fast 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3Health News:Injury-Linked Deaths Vary Widely Among States 2
... The board of,directors of Abbott ( NYSE: ABT ) today declared ... This marks the 340th consecutive quarterly dividend to be ... 2009, to shareholders of,record at the close of business on Jan. 15, ... dividend payout for 36 consecutive years --,including a 10.8 percent increase earlier ...
... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS, NASDAQ: DDSS ... of the Toronto Stock Exchange, today commented on the ... is not aware of any reason for the recent ... Fee Act (PDUFA) action date for its once-daily formulation ...
... The American Veterinary Medical,Association (AVMA) today cited ... Office of the Inspector General (OIG) report on ... that the shortage of,food animal veterinarians,( http://www.avma.org/press/releases/080208_nvmsa.asp ) ... The OIG report, ...
... access from Internet fraud, Vetted International has implemented a higher level ... ... Raleigh, NC (PRWEB) December xx, 2008 --- Vetted Internationals ... from web fraud . An application upgrade to its ...
... more allergies among kids, , , FRIDAY, Dec. 12 (HealthDay ... the rise, with more and more children being diagnosed ... providing nut-free areas. , But, at least one expert ... hysteria over potential nut exposures. What,s worse, schools may ...
... Even as the Obama,Administration sets its sights on ... public interest groups today called on the transition,team ... quickly on,another matter where action by the Treasury ... serving facts disclosing alcohol content,per serving and the ...
Other Medicine News:Health News:Labopharm Comments on Recent Trading Activity 2Health News:AVMA Calls for Increased Veterinary Oversight in Meat Production; Cites USDA Audit Report Initiated After Hallmark/Westland Recall 2Health News:AVMA Calls for Increased Veterinary Oversight in Meat Production; Cites USDA Audit Report Initiated After Hallmark/Westland Recall 3Health News:To Further Combat Internet Fraud, Heightened Security Levels are Implemented by Vetted International 2Health News:To Further Combat Internet Fraud, Heightened Security Levels are Implemented by Vetted International 3Health News:Nut Bans in Schools May Be Spurring Hysteria 2Health News:Nut Bans in Schools May Be Spurring Hysteria 3Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 2Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 3Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 4Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 5Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 6
(Date:5/22/2012)... Corporation (NYSE: POL ), a premier global ... announced it is expanding its successful distribution business into ... market will initially focus on healthcare applications and could ... well as sales and customer service functions, will be ... location in close proximity to many key customers in ...
(Date:5/22/2012)... and TEL AVIV, Israel, May 22, 2012 ... leader focused on delivering mixed-signal semiconductors, modules ... markets, today announced that it has signed ... a leading Israeli stocking representative and distributor, ... success of Cephasonics, embedded-ultrasound product offering in ...
(Date:5/22/2012)... 22, 2012  Accident Fund Holdings, Inc., the ... the United States, has begun the transition from ... new pharmacy benefit manager.  Express Scripts leverages its ... team of experienced researchers to develop innovative solutions ... for injured workers .  Accident Fund Holdings ...
Breaking Medicine Technology:PolyOne Announces Expansion in Costa Rica with Healthcare-Focused Distribution Services 2PolyOne Announces Expansion in Costa Rica with Healthcare-Focused Distribution Services 3PolyOne Announces Expansion in Costa Rica with Healthcare-Focused Distribution Services 4Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel 2Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager 2Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 1Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 2Too Few Americans Get HIV Test Early Enough 50100 1Too Few Americans Get HIV Test Early Enough 50100 2Too Few Americans Get HIV Test Early Enough 50100 3UnitedHealthcare and Fusion Sleep Announce New Agreement 50096 1UnitedHealthcare and Fusion Sleep Announce New Agreement 50096 2
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today ... Phase 3,clinical trial were published in the August ... that treatment with Kuvan results in significant,reductions in ... an investigational oral small molecule for the treatment ...
... Texas, Aug. 13 Lexicon,Pharmaceuticals, Inc. (Nasdaq: ... an oral presentation at the American Chemical Society ... August 21, 2007,at 2:50 p.m. Eastern Time. The ... serotonin levels by enzyme inhibitors for the,potential treatment ...
Other Medicine Technology:Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 2Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 3Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 4Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 5Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate 2Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate 3
18" Penrose drains...
Offers a more constant suction profile than three-spring evacuators, resulting in the potential for improved tissue approximation and reduced risk of hematoma....
Reliavac® 100cc low suction evacuator kits with flat drains and Y-connector tubing...
Used with T-tubes to collect drainage after cholecystectomy. Includes T-tube adapter and two adjustable latex rubber belts....
Medicine Products: